ACE2 and COVID-19: Second, recent reports indicated ACE2 was highly expressed in the sinonasal cavity and pulmonary alveoli, proposing a hypothesis that ACE2 expression and distribution contribute to disease severities in paediatric patients with COVID-19 35.